We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Tranylcypromine tablets 10mg (Mercury Pharmaceuticals)
Section 19A approved medicine
(Approval lapsed) Tranylcypromine tablets 10mg (Mercury Pharmaceuticals)
Section 19A approval holder
Boucher and Muir Pty Ltd trading as BNM Group ABN 58 000 140 474
Phone
02 9431 6333
Approved until
Status
Expired
Medicines in short supply/unavailable
PARNATE tranylcypromine (as sulphate) 10mg film coated tablet blister pack - ARTG 174086
Indication(s)
Treatment of symptoms of depressive illness especially where treatment with other types of antidepressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties.